Acalabrutinib in Combination With Rituximab and R-miniCHOP in OldEr Adults With Untreated Diffuse Large B-Cell Lymphoma
Conditions:   Large B-cell Lymphoma;   Diffuse Large B Cell Lymphoma Interventions:   Drug: R-miniCHOP + Acalabrutinib;   Drug: R-miniCHOP Sponsors:   Universität des Saarlandes;   University of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology (IMISE);   Saarland Universtity Medical Center, Radiology;   University Hospital Regensburg, Nuclear Medicine;   University Hospital of Würzburg, Pathology;   University Hospital of Gießen and Marburg, Molecular Pathology;   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 20, 2023 Category: Research Source Type: clinical trials